furosemide has been researched along with etilefrine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Sassnau, R | 1 |
Badra, G; El-Haggar, S; El-Said, H; Ibrahim, O; Radwan, H | 1 |
6 other study(ies) available for furosemide and etilefrine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
[Case report. House-cat, castrated male, sixteen-and-a-half years old].
Topics: Adrenergic Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Diagnosis, Differential; Diuretics; Etilefrine; Flumethasone; Furosemide; Male; Meningoencephalitis; Orchiectomy | 1997 |
Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Biomarkers; C-Reactive Protein; Creatinine; Diuretics; Etilefrine; Furosemide; Humans; Interleukin-6; Leptin; Liver Cirrhosis; Saline Solution, Hypertonic; Sodium | 2022 |